Table 2.

Summary table of articles included in the systematic review.

Authors Year GR, LoE	Design	Sample	Age (Aver)	Type of CP/GMFCS	Measurement/Tools	Performance of Evaluation	N Sessions, Temporality	Results
Jung et al. 2021 [57] A, 1b	RCT Cross-over	n = 24 TFB1 = 24 TFB2 = 24	6.17	Spastic diplegia (I–II)	STV: walking speed, cadence, step length, stride length, single support time, double support time MT: 3D-MAS	Pre/Post-intervention	1 ses (30 m	Post-TFB intervention, showed significant improvements in walking speed, cadence, step length, stride length, single support time, and double support time
Skublewska-Paszkowska et al. 2018 [58] C,4	EDS	n = 1 TTO = 1	5	Spastic diplegia (II)	STV: walking speed, cadence, step time, step length MT:3D-MAS	Pre/Post-intervention (w-wh TTO in both cases)	60 ses, 12 week	Significant improvement measured post-intervention without TTO in walking speed. Significant improvement measured post-intervention with TTO in stabilisation of step length
Degelaen et al. 2016 [33] B,3b	QED	n = 31 CP = 15 TDC = 16	7.27	Spastic diplegia (I–II)	STV: walking speed, cadence, step length MT:3D-MAS	Own clothes/ wearing FBS	1 ses	CP group wearing FBS, showed significant improvements in walking speed (p < 0.003) and cadence (p < 0.001), but not in step length
Kim et al. 2016 [59] A, 1b	RCT	n = 17 AST/NDT = 8 NDT = 9	5.64	Spastic diplegia, cuadriplegia (I–II)	STV: walking speed, cadence, step length, stride length, step length, and stride length symmetry MT:3D-MAS	Pre/Post-intervention	AST/NDT: 60 ses AST: 30 m/ses,1 ses/day, 5 days/week, 6 weeks NDT: 30 m/ses, 2 ses/day, 5 day/week, 6 weeks NDT: 60 ses 30 m/ses, 2 ses/day, 5 day/week, 6 weeks	AST + NDT group showed significant increase in walking speed, cadence, and step length symmetry (p < 0.001, 0.003, 0.027) NDT group improved step length and stride length symmetry (p = 0.006, 0.018) None of the groups showed improvement in stride length
Lee 2016 [60] C,4	CS	n = 2 AST = 2	4.5	Spastic diplegia (II)	STV: walking speed, cadence, step length, stride length MT: 3D-MAS	Pre/Post-intervention	20 ses (60 m), 5 day/week, 4 weeks	Both cases showed improvement in cadence, only one showed improvement in step length symmetry and walking speed. Results for step length and stride length were variable in each case.
Chang et al. 2015 [61] A, 1b	RCT Cross-over	n = 9 ESO 1 = 9 ESO 2 = 9	8.73	Spastic diplegia (I–II)	STV: walking speed, cadence, stride length MT: 3D-MAS	Own clothes/ wearing ESO	1 ses (10 m)	Significant changes between ESO control, showed an increase in walking speed (p = 0.036), cadence (p = 0.005), and stride length (p = 0.011), wearing ESO
Abd El-Kafy 2014 [62] A, 1b	RCT	n = 57 NO = 18 TTG = 16 TTG + AFO = 17	7.3	Spastic diplegia (I–II)	STV: walking speed, cadence, stride length MT: 3D-MAS	Pre/Post-intervention	60 ses (2 h), 1 ses/day, 5 days/week, 12 weeks	Significant post-intervention differences among three groups in walking speed, stride length, and cadence (p = 0.03, 0.001, 0.011). Best improvements of all gait parameters were shown in group C
Ko et al. 2014 [63] C,4	EDS	n = 1 AST = 1	8	Spastic diplegia (III)	STV: walking speed, stride time, stride length, stride width MT: 3D-MAS, 10-MWT	Pre/Post-intervention (1–25 ses) 10-MWT: each ses	18 ses (50 m), 1 ses/day, 1 day/week, 18 weeks	Significant improvement post-treatment in walking speed, stride length, stride width, and step time. 10-MWT improved after each session and growing up until the end of intervention.
Christy et al. 2012 [35] C,4	QED Follow up	n = 17 TST = 17	7.6	Spastic, hypotonic, athetoid, ataxic diplegia cuadriplegia triplegia (I–III)	STV: cadence MT: step activity monitor	Pre/Post-intervention (I. effects, 3 months/later)	15 ses (4 h), 1 ses/day, 5 day/week, 3 weeks	Immediate post-intervention and follow-up showed trends of improvements in cadence, but there was no significant improvement immediately after or at 3 months compared to pre-intervention
Bailes et al. 2010 [34] C,4	CS	n = 2 TST = 2	7.5	Spastic diplegia (III)	STV: walking speed, cadence, single support time, double support time, step length, stride length MT: 3D-MAS	Pre/Post-intervention (4 d/later)	15 ses (4 h), 1 ses/day, 5 days/week, 3 weeks	Both subjects showed post-intervention improvement in walking speed and cadence. Only one had changes in double support time and single support time. No significant changes were reported in stride length or step length in any case
Matthews et al. 2009 [32] C,4	CS	n = 8 DEFO = 8	5.5	Spastic diplegia (I–III)	STV: walking speed MT: 10-MWT	Pre/During/ Post-intervention (Immediate effects and 6 w/later)	30 ses (8 h) 1 ses/day, 5 day/week 6 weeks	Five subjects showed significant changes in walking time and four in walking time variation, between pre-intervention and during intervention in both cases. However, changes were not uniform
Flanagan et al. 2009 [31] C,4	QED	n = 5 TTG = 5	7–13	Spastic diplegia (I)	STV: walking speed, cadence, step length, stride length MT: 3D-MAS	Pre/Post-intervention (I. effects with/without suit, 2 and 4 months/later without suit)	84 ses, 1 ses/day, 5 days/week, 12 weeks	There were no significant pre/post-intervention changes in spatio-temporal gait parameters

(AFO) Rigid foot and ankle orthosis; (AST) Adeli suit treatment; (CP) Cerebral palsy; (CS) Case series; (d) Day; (DEFO) Elastomeric tissue dynamic orthosis; (EDS) Experimental design of a subject; (ESO1) External strap orthosis evaluation 1; (ESO2): External strap orthosis evaluation 2; (FBS) Full-body suit; (GR) Grade of Recommendation; (GMFCS) Gross Motor Function Classification System; (h) Hours; (LoE) Level of Evidence; (m) Minutes; (3D-MAS) Three-dimensional movement analysis system; (MT) Measurement tool; (10-MWT) Ten-meter walk test; (N) Total number of patients; (NDT) Neurodevelopmental treatment; (NO) No orthosis; (QED) Quasi-experimental design; (RCT) Randomised clinical trial; (ses) sessions; (STV) Spatio-temporal variables; (TDC) Typically developing children; (TFB 1) Theratogs full body evaluation 1; (TBF 2): Theratog full body evaluation 2; (TST) Therasuit; (TTG) Theratog; (TTO) T-shirt and trouser orthosis; (w) Weeks.